6877 Stock Overview
An investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
CLSA Premium Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.09 |
| 52 Week High | HK$0.15 |
| 52 Week Low | HK$0.071 |
| Beta | 1.48 |
| 11 Month Change | -18.18% |
| 3 Month Change | -6.25% |
| 1 Year Change | n/a |
| 33 Year Change | -30.77% |
| 5 Year Change | -56.31% |
| Change since IPO | -80.65% |
Recent News & Updates
Shareholder Returns
| 6877 | HK Capital Markets | HK Market | |
|---|---|---|---|
| 7D | -8.2% | -1.6% | 1.6% |
| 1Y | n/a | 18.8% | 10.1% |
Return vs Industry: Insufficient data to determine how 6877 performed against the Hong Kong Capital Markets industry.
Return vs Market: Insufficient data to determine how 6877 performed against the Hong Kong Market.
Price Volatility
| 6877 volatility | |
|---|---|
| 6877 Average Weekly Movement | 15.5% |
| Capital Markets Industry Average Movement | 14.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 6877's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: Insufficient data to determine 6877's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 13 | n/a | www.clsapremium.com |
CLSA Premium Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. The company operates through Healthcare Products and Margin Dealing segments. It also offers leveraged foreign exchange trading, commodity and index trading, leveraged bullion, and other trading services.
CLSA Premium Limited Fundamentals Summary
| 6877 fundamental statistics | |
|---|---|
| Market cap | HK$201.30m |
| Earnings (TTM) | HK$12.16m |
| Revenue (TTM) | HK$112.55m |
15.1x
P/E Ratio1.6x
P/S RatioIs 6877 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6877 income statement (TTM) | |
|---|---|
| Revenue | HK$112.55m |
| Cost of Revenue | HK$67.51m |
| Gross Profit | HK$45.03m |
| Other Expenses | HK$32.88m |
| Earnings | HK$12.16m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.006 |
| Gross Margin | 40.01% |
| Net Profit Margin | 10.80% |
| Debt/Equity Ratio | 0% |
How did 6877 perform over the long term?
See historical performance and comparison